Newton-based Thermalin plans human tests of concentrated insulin next year
July 28, 2014 at 12:51 PM EDT
As the number of diabetics worldwide skyrockets, a small Newton company developing new types of insulin has closed on $1...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.